Oncology Institute (TOIIW) Non-Current Assets (2019 - 2026)

Oncology Institute (TOIIW) has reported Non-Current Assets for 8 consecutive years, with $51.4 million the latest figure, recorded in Q1 2026.

• Non-Current Assets for Q1 2026 came in at $51.4 million, down 10.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $211.8 million (down 13.06% YoY), and the FY2025 annual result was $51.9 million, down 13.91% from the prior year.
• Non-Current Assets was $51.4 million for Q1 2026 at Oncology Institute, down from $51.9 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $140.2 million in Q3 2022 and troughed at $51.4 million in Q1 2026.
• Average Non-Current Assets over 5 years is $76.9 million, with a median of $63.4 million recorded in 2024.
• The widest YoY moves for Non-Current Assets: up 165.77% in 2022, down 71.05% in 2022.
• Over 5 years, Non-Current Assets stood at $131.2 million in 2022, then slumped by 49.91% to $65.7 million in 2023, then fell by 8.29% to $60.3 million in 2024, then dropped by 13.91% to $51.9 million in 2025, then dropped by 1.04% to $51.4 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $51.4 million in Q1 2026, $51.9 million in Q4 2025, and $53.5 million in Q3 2025.